Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
about
Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis.Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection modelsPharmacodynamics of oritavancin (LY333328) in a neutropenic-mouse thigh model of Staphylococcus aureus infectionBeneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis.
P2860
Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Pharmacodynamics of RP 59500 ( ...... n an in vitro infection model.
@ast
Pharmacodynamics of RP 59500 ( ...... n an in vitro infection model.
@en
type
label
Pharmacodynamics of RP 59500 ( ...... n an in vitro infection model.
@ast
Pharmacodynamics of RP 59500 ( ...... n an in vitro infection model.
@en
prefLabel
Pharmacodynamics of RP 59500 ( ...... n an in vitro infection model.
@ast
Pharmacodynamics of RP 59500 ( ...... n an in vitro infection model.
@en
P2093
P2860
P356
P1476
Pharmacodynamics of RP 59500 ( ...... in an in vitro infection model
@en
P2093
P2860
P304
P356
10.1128/AAC.41.6.1359
P407
P577
1997-06-01T00:00:00Z